Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
20004 | 481 | 35.2 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
10 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 134299 |
140 | 2 | IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY | 23462 |
20004 | 1 | CYTOKINE INDUCED KILLER CELLS//CIK CELLS//CIK | 481 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CYTOKINE INDUCED KILLER CELLS | authKW | 8442025 | 32% | 85% | 156 |
2 | CIK CELLS | authKW | 1413146 | 7% | 70% | 32 |
3 | CIK | authKW | 954868 | 4% | 79% | 19 |
4 | CYTOKINE INDUCED KILLER | authKW | 609423 | 2% | 80% | 12 |
5 | CYTOKINE INDUCED KILLER CIK CELLS | authKW | 609423 | 2% | 80% | 12 |
6 | IMMUNO CELL THERAPY | authKW | 264507 | 1% | 83% | 5 |
7 | AUTOLOGOUS IMMUNE ENHANCEMENT THERAPY | authKW | 253928 | 1% | 100% | 4 |
8 | DC CIK | authKW | 226719 | 1% | 71% | 5 |
9 | ADOPTIVE IMMUNOTHERAPY | authKW | 209475 | 10% | 7% | 46 |
10 | CD3CD56 CELLS | authKW | 190446 | 1% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 3700 | 46% | 0% | 219 |
2 | Medicine, Research & Experimental | 1850 | 24% | 0% | 114 |
3 | Immunology | 1404 | 27% | 0% | 129 |
4 | Hematology | 1170 | 16% | 0% | 75 |
5 | Cell & Tissue Engineering | 1027 | 4% | 0% | 21 |
6 | Biotechnology & Applied Microbiology | 154 | 9% | 0% | 43 |
7 | Transplantation | 83 | 3% | 0% | 15 |
8 | Cell Biology | 73 | 8% | 0% | 40 |
9 | Pharmacology & Pharmacy | 60 | 9% | 0% | 44 |
10 | Gastroenterology & Hepatology | 45 | 4% | 0% | 18 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | POLIKLIN S HAMATOL ONKOL | 142833 | 1% | 75% | 3 |
2 | LUNG CANC PREVENT | 126964 | 0% | 100% | 2 |
3 | ONCOL SCI CELL THER Y CANC | 126964 | 0% | 100% | 2 |
4 | PEDIAT BLOOD MARROW DIS | 126964 | 0% | 100% | 2 |
5 | SJ TECHNOVILLE | 126964 | 0% | 100% | 2 |
6 | BIOTHER Y | 121308 | 8% | 5% | 37 |
7 | CENTRUM SOMAT GENTHER IE | 84641 | 0% | 67% | 2 |
8 | GERIATR HEMATOL | 65286 | 1% | 17% | 6 |
9 | 309 HOSP | 63482 | 0% | 100% | 1 |
10 | ADV CELLULAR THER IES | 63482 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CYTOTHERAPY | 13988 | 4% | 1% | 19 |
2 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 5826 | 4% | 0% | 20 |
3 | ONCOLOGY LETTERS | 5631 | 5% | 0% | 22 |
4 | JOURNAL OF IMMUNOTHERAPY | 5418 | 2% | 1% | 12 |
5 | CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | 5250 | 2% | 1% | 11 |
6 | PROGRESS IN TUMOR RESEARCH | 3525 | 0% | 6% | 1 |
7 | IMMUNOTHERAPY | 3162 | 1% | 1% | 6 |
8 | INTERNATIONAL IMMUNOPHARMACOLOGY | 2465 | 3% | 0% | 13 |
9 | CLINICAL & DEVELOPMENTAL IMMUNOLOGY | 1844 | 1% | 1% | 5 |
10 | ONCOIMMUNOLOGY | 1652 | 1% | 1% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYTOKINE INDUCED KILLER CELLS | 8442025 | 32% | 85% | 156 | Search CYTOKINE+INDUCED+KILLER+CELLS | Search CYTOKINE+INDUCED+KILLER+CELLS |
2 | CIK CELLS | 1413146 | 7% | 70% | 32 | Search CIK+CELLS | Search CIK+CELLS |
3 | CIK | 954868 | 4% | 79% | 19 | Search CIK | Search CIK |
4 | CYTOKINE INDUCED KILLER | 609423 | 2% | 80% | 12 | Search CYTOKINE+INDUCED+KILLER | Search CYTOKINE+INDUCED+KILLER |
5 | CYTOKINE INDUCED KILLER CIK CELLS | 609423 | 2% | 80% | 12 | Search CYTOKINE+INDUCED+KILLER+CIK+CELLS | Search CYTOKINE+INDUCED+KILLER+CIK+CELLS |
6 | IMMUNO CELL THERAPY | 264507 | 1% | 83% | 5 | Search IMMUNO+CELL+THERAPY | Search IMMUNO+CELL+THERAPY |
7 | AUTOLOGOUS IMMUNE ENHANCEMENT THERAPY | 253928 | 1% | 100% | 4 | Search AUTOLOGOUS+IMMUNE+ENHANCEMENT+THERAPY | Search AUTOLOGOUS+IMMUNE+ENHANCEMENT+THERAPY |
8 | DC CIK | 226719 | 1% | 71% | 5 | Search DC+CIK | Search DC+CIK |
9 | ADOPTIVE IMMUNOTHERAPY | 209475 | 10% | 7% | 46 | Search ADOPTIVE+IMMUNOTHERAPY | Search ADOPTIVE+IMMUNOTHERAPY |
10 | CD3CD56 CELLS | 190446 | 1% | 100% | 3 | Search CD3CD56+CELLS | Search CD3CD56+CELLS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SCHMEEL, LC , SCHMEEL, FC , COCH, C , SCHMIDT-WOLF, IGH , (2015) CYTOKINE-INDUCED KILLER (CIK) CELLS IN CANCER IMMUNOTHERAPY: REPORT OF THE INTERNATIONAL REGISTRY ON CIK CELLS (IRCC).JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. VOL. 141. ISSUE 5. P. 839 -849 | 49 | 83% | 18 |
2 | MESIANO, G , TODOROVIC, M , GAMMAITONI, L , LEUCI, V , DIEGO, LG , CARNEVALE-SCHIANCA, F , FAGIOLI, F , PIACIBELLO, W , AGLIETTA, M , SANGIOLO, D , (2012) CYTOKINE-INDUCED KILLER (CIK) CELLS AS FEASIBLE AND EFFECTIVE ADOPTIVE IMMUNOTHERAPY FOR THE TREATMENT OF SOLID TUMORS.EXPERT OPINION ON BIOLOGICAL THERAPY. VOL. 12. ISSUE 6. P. 673-684 | 51 | 71% | 58 |
3 | GIRAUDO, L , GAMMAITONI, L , CANGEMI, M , ROTOLO, R , AGLIETTA, M , SANGIOLO, D , (2015) CYTOKINE-INDUCED KILLER CELLS AS IMMUNOTHERAPY FOR SOLID TUMORS: CURRENT EVIDENCE AND PERSPECTIVES.IMMUNOTHERAPY. VOL. 7. ISSUE 9. P. 999 -1010 | 62 | 65% | 0 |
4 | JAKEL, CE , SCHMIDT-WOLF, IGH , (2014) AN UPDATE ON NEW ADOPTIVE IMMUNOTHERAPY STRATEGIES FOR SOLID TUMORS WITH CYTOKINE-INDUCED KILLER CELLS.EXPERT OPINION ON BIOLOGICAL THERAPY. VOL. 14. ISSUE 7. P. 905-916 | 44 | 79% | 13 |
5 | SANGIOLO, D , (2011) CYTOKINE INDUCED KILLER CELLS AS PROMISING IMMUNOTHERAPY FOR SOLID TUMORS.JOURNAL OF CANCER. VOL. 2. ISSUE . P. 363-368 | 35 | 78% | 62 |
6 | SCHMEEL, FC , SCHMEEL, LC , GAST, SM , SCHMIDT-WOLF, IGH , (2014) ADOPTIVE IMMUNOTHERAPY STRATEGIES WITH CYTOKINE-INDUCED KILLER (CIK) CELLS IN THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES.INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. VOL. 15. ISSUE 8. P. 14632 -14648 | 32 | 84% | 8 |
7 | INTRONA, M , GOLAY, J , RAMBALDI, A , (2013) CYTOKINE INDUCED KILLER (CIK) CELLS FOR THE TREATMENT OF HAEMATOLOGICAL NEOPLASMS.IMMUNOLOGY LETTERS. VOL. 155. ISSUE 1-2. P. 27-30 | 32 | 84% | 12 |
8 | THANENDRARAJAN, S , KIM, Y , SCHMIDT-WOLF, I , (2012) NEW ADOPTIVE IMMUNOTHERAPY STRATEGIES FOR SOLID TUMOURS WITH CIK CELLS.EXPERT OPINION ON BIOLOGICAL THERAPY. VOL. 12. ISSUE 5. P. 565-572 | 28 | 90% | 25 |
9 | GUO, YL , HAN, WD , (2015) CYTOKINE-INDUCED KILLER (CIK) CELLS: FROM BASIC RESEARCH TO CLINICAL TRANSLATION.CHINESE JOURNAL OF CANCER. VOL. 34. ISSUE . P. - | 37 | 66% | 3 |
10 | IUDICONE, P , FIORAVANTI, D , CICCHETTI, E , ZIZZARI, IG , PANDOLFI, A , SCOCCHERA, R , FAZZINA, R , PIERELLI, L , (2016) INTERLEUKIN-15 ENHANCES CYTOKINE INDUCED KILLER (CIK) CYTOTOXIC POTENTIAL AGAINST EPITHELIAL CANCER CELL LINES VIA AN INNATE PATHWAY.HUMAN IMMUNOLOGY. VOL. 77. ISSUE 12. P. 1239 -1247 | 27 | 93% | 0 |
Classes with closest relation at Level 1 |